Arkolith/Insider Trading/DNA/Form 4

Kelly Jason R

See remarks, DirectorGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Apr 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2026Sell(S)110K$6.40$702K316K
Apr 8, 2026Option exercise(M)213K——523K
Apr 8, 2026Sell(S)97K$6.93$672K426K
Apr 7, 2026Option exercise(M)213K——310K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 8, 2026Option exercise(M)213K——0
Apr 7, 2026Option exercise(M)213K——213K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-024743) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML